M I Canto

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
    Marcia Irene Canto
    Division of Gastroenterology, Johns Hopkins University, The Sol Goldman Pancreatic Cancer Research Center, 1830 E Monument Street, Room 427, Baltimore, MD 21205, USA
    Gut 62:339-47. 2013
  2. ncbi Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
    Marcia Irene Canto
    Department of Medicine Division of Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Gastroenterology 142:796-804; quiz e14-5. 2012
  3. ncbi Strategies for screening for pancreatic adenocarcinoma in high-risk patients
    Marcia Irene Canto
    Department of Medicine Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    Semin Oncol 34:295-302. 2007
  4. ncbi Endomicroscopy of Barrett's Esophagus
    Marcia Irene Canto
    Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, Room 427, Baltimore, MD 21205, USA
    Gastroenterol Clin North Am 39:759-69. 2010
  5. ncbi Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study
    Marcia Irene Canto
    Depatment of Medicine Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Clin Gastroenterol Hepatol 4:766-81; quiz 665. 2006
  6. ncbi Screening for pancreatic neoplasia in high-risk individuals: who, what, when, how?
    Marcia Irene Canto
    Department of Medicine and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD 21287 4461, USA
    Clin Gastroenterol Hepatol 3:S46-8. 2005
  7. ncbi Chromoendoscopy and magnifying endoscopy for Barrett's esophagus
    Marcia Irene Canto
    Department of Medicine and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD 21287 4461, USA
    Clin Gastroenterol Hepatol 3:S12-5. 2005
  8. ncbi Barrett's esophagus
    Marcia Irene Canto
    Department of Medicine and Oncology, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, 1830 E Monument Street, Room 426, Baltimore, MD 21205, USA
    Gastrointest Endosc Clin N Am 15:83-92, ix. 2005
  9. ncbi Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
    Marcia Irene Canto
    Department of Medicine Gastroenterology, Johns Hopkins Medical Institution, Baltimore, MD 21205, USA
    Clin Gastroenterol Hepatol 2:606-21. 2004
  10. ncbi Screening and surveillance approaches in familial pancreatic cancer
    Marcia Irene Canto
    Department of Medicine Gastroenterology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, 1830 East Monument Street, Baltimore, MD 21205, USA
    Gastrointest Endosc Clin N Am 18:535-53, x. 2008

Collaborators

Detail Information

Publications29

  1. ncbi International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
    Marcia Irene Canto
    Division of Gastroenterology, Johns Hopkins University, The Sol Goldman Pancreatic Cancer Research Center, 1830 E Monument Street, Room 427, Baltimore, MD 21205, USA
    Gut 62:339-47. 2013
    ..Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia...
  2. ncbi Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
    Marcia Irene Canto
    Department of Medicine Division of Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    Gastroenterology 142:796-804; quiz e14-5. 2012
    ..We determined the baseline prevalence and characteristics of pancreatic abnormalities using 3 imaging tests to screen asymptomatic, high-risk individuals (HRIs)...
  3. ncbi Strategies for screening for pancreatic adenocarcinoma in high-risk patients
    Marcia Irene Canto
    Department of Medicine Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    Semin Oncol 34:295-302. 2007
    ..Long-term, multi-prospective studies are needed to determine if screening for early pancreatic neoplasia and timely intervention results in decreased pancreatic cancer incidence and mortality in high-risk individuals...
  4. ncbi Endomicroscopy of Barrett's Esophagus
    Marcia Irene Canto
    Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, Room 427, Baltimore, MD 21205, USA
    Gastroenterol Clin North Am 39:759-69. 2010
    ..This article discusses the scientific literature related to clinical use of CLE for BE, the techniques for performing CLE in the esophagus, and the potential future directions for CLE in BE and esophageal cancer diagnosis and treatment...
  5. ncbi Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study
    Marcia Irene Canto
    Depatment of Medicine Gastroenterology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Clin Gastroenterol Hepatol 4:766-81; quiz 665. 2006
    ..This study screened for early pancreatic neoplasia and compared the pancreatic abnormalities in high-risk individuals and control subjects...
  6. ncbi Screening for pancreatic neoplasia in high-risk individuals: who, what, when, how?
    Marcia Irene Canto
    Department of Medicine and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD 21287 4461, USA
    Clin Gastroenterol Hepatol 3:S46-8. 2005
    ..This article summarizes the available published data and preliminary results and discusses the different approaches to screening for pancreatic neoplasia at 2 university-based programs in the United States...
  7. ncbi Chromoendoscopy and magnifying endoscopy for Barrett's esophagus
    Marcia Irene Canto
    Department of Medicine and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD 21287 4461, USA
    Clin Gastroenterol Hepatol 3:S12-5. 2005
    ..Furthermore, this article discusses the possible clinical use of magnification endoscopy and chromoendoscopy in evaluating patients with chronic gastroesophageal reflux disease and Barrett's esophagus...
  8. ncbi Barrett's esophagus
    Marcia Irene Canto
    Department of Medicine and Oncology, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, 1830 E Monument Street, Room 426, Baltimore, MD 21205, USA
    Gastrointest Endosc Clin N Am 15:83-92, ix. 2005
    ..This article discusses the scientific evidence for the use of EUS in BE or early esophageal adenocarcinoma...
  9. ncbi Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
    Marcia Irene Canto
    Department of Medicine Gastroenterology, Johns Hopkins Medical Institution, Baltimore, MD 21205, USA
    Clin Gastroenterol Hepatol 2:606-21. 2004
    ..We prospectively evaluated the feasibility of screening for pancreatic neoplasia in high-risk individuals...
  10. ncbi Screening and surveillance approaches in familial pancreatic cancer
    Marcia Irene Canto
    Department of Medicine Gastroenterology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, 1830 East Monument Street, Baltimore, MD 21205, USA
    Gastrointest Endosc Clin N Am 18:535-53, x. 2008
    ....
  11. ncbi Chromoscopy of intestinal metaplasia in Barrett's esophagus
    M I Canto
    The Johns Hopkins Division of Gastroenterology and Hepatology, Baltimore, Maryland 21205, USA
    Endoscopy 34:330-6. 2002
  12. ncbi Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study
    M I Canto
    Division of Gastroenterology, University Hospitals of Cleveland and Veterans Administration Medical Center Case Western Reserve University, Ohio, USA
    Endoscopy 33:391-400. 2001
    ..We prospectively evaluated the methylene blue staining properties of dysplastic and nondysplastic Barrett's esophagus and the association of these properties with the risk for dysplasia and cancer...
  13. ncbi Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer
    R H Hruban
    Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Dig Dis 19:76-84. 2001
    ....
  14. ncbi Barrett's esophagus and early esophageal cancer
    Marcia Irene Canto
    Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Gastrointest Endosc 56:S66-8. 2002
  15. ncbi A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus
    Zhe Jin
    Gastroenterology Division, Johns Hopkins University, Baltimore, MD 21287, USA
    Cancer Res 69:4112-5. 2009
    ..118, respectively) in all 3 models. A methylation biomarker-based panel to predict neoplastic progression in BE has potential clinical value in improving both the efficiency of surveillance endoscopy and the early detection of neoplasia...
  16. ncbi Management of high-grade dysplasia in patients with Barrett's esophagus
    Elizabeth Montgomery
    Department of Pathology, Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21231, USA
    Clin Gastroenterol Hepatol 4:1434-9. 2006
    ..Emerging endoscopic techniques offer an opportunity for better evaluation of patients with Barrett's-associated neoplasia...
  17. ncbi Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial
    Kerry B Dunbar
    Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Gastrointest Endosc 70:645-54. 2009
    ..The detection of high-grade dysplasia and cancer in Barrett's esophagus (BE) can be challenging. Confocal laser endomicroscopy (CLE) allows in vivo visualization of mucosal histology during endoscopy...
  18. ncbi Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus
    E I Heath
    Departments of Oncology, Surgery, Medicine, and Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287 8934, USA
    J Clin Oncol 18:868-76. 2000
    ....
  19. ncbi The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract
    M B Wallace
    Department of Medicine, Mayo Clinic, Jacksonville, FL, USA
    Aliment Pharmacol Ther 31:548-52. 2010
    ..Fluorescein is FDA-cleared for diagnostic angiography of the retina. For these indications, the safety profile of fluorescein has been well-documented; however, to date, fluorescein is not cleared for use with CLE...
  20. ncbi The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians
    M Cruz-Correa
    The Johns Hopkins Hospital, Blalock 413, 600 N Wolfe St, Baltimore, MD 21287, USA
    Arch Intern Med 161:2588-95. 2001
    ..Our objective is to assess physicians' awareness of agreement with and adherence to these guidelines...
  21. ncbi The utility of contrast-enhanced endoscopic ultrasound in monitoring ethanol-induced pancreatic tissue ablation: a pilot study in a porcine model
    S A Giday
    Department of Medicine, Division of Gastroenterology, Johns Hopkins Hospital, Baltimore, Maryland 21205, USA
    Endoscopy 39:525-9. 2007
    ..The aim of our study was to evaluate local effects of intrapancreatic alcohol injection and the utility of contrast-enhanced endoscopic ultrasound (EUS) for its monitoring in a porcine model...
  22. ncbi Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model
    S A Giday
    Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore 21205, USA
    Endoscopy 43:296-9. 2011
    ..A proprietary nanopowder (TC-325) has been proven to be effective in high pressure bleeding from external wounds. The efficacy and safety of TC-325 were assessed in a survival gastrointestinal bleeding animal model...
  23. ncbi Gallbladder response to a second dose of cholecystokinin during the same imaging study
    S Sostre
    Division of Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205
    Eur J Nucl Med 19:964-5. 1992
    ..5 +/- 19%). Pretreatment with CCK does not preclude GB contraction evaluation with a second dose of CCK. Expected GBEF values are similar to those obtained with single CCK injections...
  24. ncbi Gastrointestinal tract epithelial changes associated with taxanes: marker of drug toxicity versus effect
    Jason A Daniels
    Department of Pathology, Johns Hopkins Hospital, Baltimore, MD 21231, USA
    Am J Surg Pathol 32:473-7. 2008
    ..Further, epithelial changes associated with taxanes can mimic high-grade dysplasia (HGD) in non-neoplastic gastrointestinal (GI) tract mucosa. Similar changes associated with colchicine are only seen in patients with toxicity...
  25. ncbi Chemoprevention for Barrett's esophagus trial. Design and outcome measures
    E I Heath
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
    Dis Esophagus 16:177-86. 2003
    ..Secondary outcomes include change from baseline in the maximal grade, extent and surface area of dysplasia. Tertiary outcomes will include measurements of various relevant biomarkers...
  26. ncbi Chromoendoscopy for Barrett's esophagus in the twenty-first century: to stain or not to stain?
    Marcia Irene Canto
    Gastrointest Endosc 64:200-5. 2006
  27. ncbi Acetic-acid chromoendoscopy for Barrett's esophagus: the "pros"
    Marcia Irene Canto
    Gastrointest Endosc 64:13-6. 2006
  28. ncbi Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial
    Elisabeth I Heath
    Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA
    J Natl Cancer Inst 99:545-57. 2007
    ....
  29. ncbi The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists
    Cary P Gross
    Primary Care Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Am J Gastroenterol 97:279-86. 2002
    ..There was a significant increase in ablation use during our study period, and the characteristic that was most strongly associated with ablation use was the belief that colleagues used it...